Honeybees have defensive weapons at both ends of their bodies, Greek and
French researchers have found: They can not only sting their enemies, as has
long been known, but they can also bite them, injecting a venom that paralyzes
invaders. The venom might be useful as an anesthetic in humans and other
animals, the researchers speculate, and a British company has already patented
the application and conducted preliminary tests suggesting that the venom works
much like the well-known lidocaine.
The discovery was inadvertent. A team led by biologist Alexandros
Papachristoforou of the Aristotle University of Thessaloniki in Greece was
studying ways to control wax moths. The moths are a serious problem for
beekeepers, invading hives, consuming wax and pollen and often destroying the
honeycomb. Using natural products on the moths, the researchers tried
2-heptanone, which is produced naturally by the bees. At first, the team
thought exposure to the chemical killed the wax moths. "However, on closer
inspection, we realized that the wax moths were merely anesthetized for a
period of one to nine minutes," Papachristoforou said. "This was
quite unexpected, so our scientific team set up a series of rigorous
experiments to find out what was really happening and came up with our
remarkable discovery."
Their findings were published
in the online journal Plos One. The research showed that the bees bite
intruders such as wax moths and varroa mites that are too small to sting. The
2-heptanone is stored in a mandibular gland in their mouth and injected into
the victim through grooves in the bee's teeth. Once the invader is
anesthetized, it can be ejected from the hive.
Commonly known as 2-H, 2-Heptanone has previously been found in bread
and wine and is generally considered harmless. Researchers had previously
believed that it was an alarm signal emitted by the bees, but the new research
suggests it has a more crucial function. Independent tests by Vita (Europe)
Ltd. of Britain show that the 2-H can act as an anesthetic on human and animal
skin and may have fewer potential side effects than lidocaine. The company is
seeking a pharmaceutical firm to help develop the 2-H for marketing.
Source: Chicago Tribune
Please share
No comments:
Post a Comment